Advertisement

Rheumatology International

, Volume 30, Issue 11, pp 1483–1487 | Cite as

Assessment of latent tuberculosis infection in Takayasu arteritis with tuberculin skin test and Quantiferon-TB Gold test

  • Omer KaradagEmail author
  • Kenan Aksu
  • Abdurrahman Sahin
  • Figen Yargucu Zihni
  • Burcin Sener
  • Nevsun Inanc
  • Umut Kalyoncu
  • Sibel Zehra Aydin
  • Sibel Ascioglu
  • Pinar Talu Ocakci
  • Sule Apras Bilgen
  • Gokhan Keser
  • Vedat Inal
  • Haner Direskeneli
  • Meral Calguneri
  • Ihsan Ertenli
  • Sedat Kiraz
Original Article

Abstract

A possible relationship between Takayasu arteritis (TA) and tuberculosis (TB) has been suggested. An increased frequency of tuberculin skin test (TST) was observed in TA patients. Quantiferon-TB Gold test (QFT) is a new in vitro assay measuring interferon-gamma response to M. tuberculosis antigens and helpful in diagnosing latent TB infection. The aim of this study was to investigate latent TB infection among TA patients by the use of both TST and QFT Gold test. Ninety-four (male/female: 7/87) TA patients fulfilling ACR 1990 TA criteria from three different university hospitals in Turkey and 107 control subjects without inflammatory diseases were included in the study. Data about medical history (TA and TB) were collected for both groups. TST and QFT were performed. TST values ≥5 mm for TA patients and ≥15 mm for controls was accepted as TST positivity. Even though TA group was older (40 ± 12 vs. 32 ± 8, P < 0.001), there was no significant difference between TA patients and controls regarding demographic characteristics. Six TA patients and one control had a history of previous TB infection (P = 0.054). Although TST positivity was higher in TA group [55 patients (62.5%) vs. 24 controls (41.4%), P = 0.008], QFT positivity was similar between two groups [21 patients (22.3%) vs. 24 controls (22.4%), P > 0.05]. QFT was negative in two of six TA patients with previous TB history. Rate of latent TB infection in TA patients measured with QFT is no more than controls. QFT seems to be a good and favorable test compared with TST in detecting LTBI in TA.

Keywords

Tuberculosis Takayasu arteritis Tuberculin skin test Quantiferon-TB Gold test 

Notes

Acknowledgments

We thank MicroELISA Unit of Clinical Pathology Laboratory Staff of Hacettepe University Hospitals for the laboratory support.

Conflict of interest statement

None.

References

  1. 1.
    Andrews J, Mason JC (2007) Takayasu’s arteritis—recent advances in imaging offer promise. Rheumatology (Oxford) 46(1):6–15CrossRefGoogle Scholar
  2. 2.
    Arnaud L, Kahn JE, Girszyn N, Piette AM, Bletry O (2006) Takayasu’s arteritis: an update on physiopathology. Eur J Intern Med 17(4):241–246CrossRefPubMedGoogle Scholar
  3. 3.
    Chauhan SK, Tripathy NK, Sinha N, Nityanand S (2006) T-cell receptor repertoire of circulating gamma delta T-cells in Takayasu’s arteritis. Clin Immunol 118(2–3):243–249CrossRefPubMedGoogle Scholar
  4. 4.
    Robles M, Reyes PA (1994) Takayasu’s arteritis in Mexico: a clinical review of 44 consecutive cases. Clin Exp Rheumatol 12(4):381–388PubMedGoogle Scholar
  5. 5.
    Mwipatayi BP, Jeffery PC, Beningfield SJ, Matley PJ, Naidoo NG, Kalla AA, Kahn D (2005) Takayasu arteritis: clinical features and management: report of 272 cases. ANZ J Surg 75(3):110–117CrossRefPubMedGoogle Scholar
  6. 6.
    Lalvani A (2007) Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy. Chest 131(6):1898–1906CrossRefPubMedGoogle Scholar
  7. 7.
    Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM et al (1990) The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33(8):1129–1134CrossRefPubMedGoogle Scholar
  8. 8.
    Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, Hoffman GS (1994) Takayasu arteritis. Ann Intern Med 120(11):919–929PubMedGoogle Scholar
  9. 9.
    Quantiferon-TB Gold IT at http://www.ellestis.com
  10. 10.
    Özkara Ş, Aktaş Z, Özkan S, Ecevit H (2003) The book for controlling tuberculosis in Turkey. p 55Google Scholar
  11. 11.
    Moraes MF, Ordway D, Oliveira L, Costa IL, Badura R, Pinheiro MN, de Graça JM, Ventura FA (1999) Cellular immune responses to Mycobacterium tuberculosis in a patient with Takayasu’s arteritis. Rev Port Cadiol 18(4):359–367Google Scholar
  12. 12.
    Matulis G, Jüni P, Villiger PM, Gadola SD (2008) Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen specific interferon gamma assay. Ann Rheum Dis 67:84–90CrossRefPubMedGoogle Scholar
  13. 13.
    Kalyoncu U, Cobanoglu N, Akdogan A, Karadag O, Kisacik B, Maras Y, Bilgen SA, Calguneri M, Ozcelik U, Kiraz S, Ertenli I (2007) Using an interferon gamma assay for the diagnosis of tuberculosis infection before using tumor necrosis factor alpha blockers. Ann Rheum Dis 66(Suppl II):175Google Scholar
  14. 14.
    Ates A, Tabuk O, Ozturk N, Aksaray S (2008) Detection of latent tuberculosis in immunosuppressed patients with rheumatic diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon-gamma assay. Ann Rheum Dis 67(Suppl II):417Google Scholar
  15. 15.
    Mori T (2009) Usefulness of interferon-gamma release assays for diagnosing TB infection and problems with these assays. J Infect Chemother 15(3):143–155CrossRefPubMedGoogle Scholar
  16. 16.
    Tozlu M, Kalyoncu U, Alp S, Unal S, Calguneri M (2009) Diagnostic accuracy of quantiferon TB test for patients with SLE and miliary tuberculosis. Rheumatol Int 29(11):1395–1396CrossRefPubMedGoogle Scholar
  17. 17.
    Bartalesi F, Vicidomini S, Goletti D, Fiorelli C, Fiori G, Melchiorre D, Tortoli E, Mantella A, Benucci M, Girardi E, Cerinic MM, Bartoloni A (2009) QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases. Eur Respir J 33(3):586–593CrossRefPubMedGoogle Scholar
  18. 18.
    Lalvani A, Millington KA (2008) Screening for tuberculosis infection prior to initiation of anti-TNF therapy. Autoimmun Rev 8(2):147–152CrossRefPubMedGoogle Scholar
  19. 19.
    Falagas ME, Voidonikola PT, Angelousi AG (2007) Tuberculosis in patients with systemic rheumatic or pulmonary diseases treated with glucocorticosteroids and the preventive role of isoniazid: a review of the available evidence. Int J Antimicrob Agents 30(6):477–486CrossRefPubMedGoogle Scholar
  20. 20.
    Villiger PM, Zellweger JP, Möller B (2009) Novel screening tools for latent tuberculosis: time to leave an old friend? Curr Opin Rheumatol 21(3):238–243CrossRefPubMedGoogle Scholar
  21. 21.
    Global tuberculosis control—epidemiology, strategy, financing WHO Report 2009. WHO/HTM/TB/2009.411Google Scholar
  22. 22.
    el Asri A, Tazi-Mezalek Z, Aouni M, Adnaoui M, Mohattane A, Bensaid Y, Maaouni A (2002) Takayasu’s disease in Morocco. Report of 47 cases. Rev Med Interne 23(1):9–20CrossRefPubMedGoogle Scholar
  23. 23.
    Hoffman GS, Merkel PA, Brasington RD, Lenschow DJ, Liang P (2004) Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Ann Rheum Dis 50(7):2296–2304Google Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Omer Karadag
    • 1
    Email author
  • Kenan Aksu
    • 2
  • Abdurrahman Sahin
    • 3
  • Figen Yargucu Zihni
    • 2
  • Burcin Sener
    • 4
  • Nevsun Inanc
    • 5
  • Umut Kalyoncu
    • 3
  • Sibel Zehra Aydin
    • 5
  • Sibel Ascioglu
    • 6
  • Pinar Talu Ocakci
    • 2
  • Sule Apras Bilgen
    • 3
  • Gokhan Keser
    • 2
  • Vedat Inal
    • 2
  • Haner Direskeneli
    • 5
  • Meral Calguneri
    • 3
  • Ihsan Ertenli
    • 3
  • Sedat Kiraz
    • 3
  1. 1.Faculty of Medicine, Department of Internal Medicine Unit of RheumatologyHacettepe UniversityÇankaya, AnkaraTurkey
  2. 2.Faculty of Medicine, Department of Internal Medicine Unit of RheumatologyEge UniversityIzmirTurkey
  3. 3.Faculty of Medicine, Department of Internal Medicine Unit of RheumatologyHacettepe UniversityAnkaraTurkey
  4. 4.Faculty of Medicine, Department of Clinical MicrobiologyHacettepe UniversityAnkaraTurkey
  5. 5.Faculty of Medicine, Department of Internal Medicine Unit of RheumatologyMarmara UniversityIstanbulTurkey
  6. 6.Faculty of Medicine, Department of Internal Medicine Unit of Infectious DiseaseHacettepe UniversityAnkaraTurkey

Personalised recommendations